title: Some considerations about cardiac toxicity of combination therapy for chronic hepatitis C.
authors: Cardiovascular Diseases Department, Baqiyatallah University of Medical Sciences, Tehran, IR Iran.
authors: Reza
authors: R
authors: Karbasi-Afshar
authors: Amin
authors: A
authors: Saburi
keywords: Combined Modality Therapy; Hepatitis C; Interferon-Gamma; Ribavirin
references: Hepat Mon. 2012 Sep;12(9):e6151
references: 23087759
references: J Clin Virol. 2010 Jan;47(1):72-5
references: 19896417
references: Hepat Mon. 2012 Aug;12(8):e6254
references: 23105944
references: Circ Cardiovasc Qual Outcomes. 2011 Jul;4(4):425-32
references: 21712519
references: Hepatogastroenterology. 2011 May-Jun;58(107-108):875-9
references: 21830408
references: J Viral Hepat. 2002 Jan;9(1):75-9
references: 11851906
references: Am J Cardiol. 2013 Jan 15;111(2):265-72
references: 23116612
references: Hepat Mon. 2011 Feb;11(2):114-8
references: 22087127
references: J Viral Hepat. 2012 May;19(5):327-31
references: 22497811
references: J Viral Hepat. 2011 Jul;18(7):e366-71
references: 21692949
references: Hepat Mon. 2012 Sep;12(9):e6390
references: 23087763
references: Gastroenterol Clin Biol. 2009 Jan;33(1 Pt 1):8-14
references: 19070444
references: Eur J Gastroenterol Hepatol. 2009 Dec;21(12):1438-40
references: 19907230
references: Eur J Gastroenterol Hepatol. 2012 Nov;24(11):1308-12
references: 22825646
references: South Med J. 2011 Aug;104(8):543-6
references: 21886060
references: J Hepatol. 2013 Jan;58(1):11-5
references: 22889957